Recent Quarter Total Invested
$12.50 M
Recent Quarter Institutional Ownership Percentage
31.66%
Total Invested of Last Quarter
$26.06 M
Ownership Percentage of Last Quarter
31.73%
BioXcel Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
ARMISTICE CAPITAL, LLC | 08/14/2024 | 2.99 M | $3.82 M | 705.18% | 9.68% |
FMR LLC | 08/13/2024 | 2.21 M | $2.82 M | -11.59% | 7.14% |
VANGUARD GROUP INC | 08/13/2024 | 970,430 | $1.24 M | -11.73% | 3.14% |
BLACKROCK INC. | 08/13/2024 | 440,685 | $564,077 | -66.82% | 1.43% |
BNP PARIBAS ARBITRAGE, SNC | 08/13/2024 | 273,135 | $349,613 | 1,155.79% | 0.88% |
GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 266,719 | $341,470 | -41.75% | 0.86% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 203,615 | $260,627 | 6.62% | 0.66% |
NORTHERN TRUST CORP | 08/14/2024 | 194,953 | $249,540 | -7.87% | 0.63% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 173,318 | $221,847 | 92.17% | 0.56% |
WELLS FARGO & COMPANY/MN | 08/13/2024 | 133,676 | $171,105 | 8.60% | 0.43% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 132,200 | $169,216 | 5.17% | 0.43% |
JANE STREET GROUP, LLC | 08/15/2024 | 125,046 | $160,059 | 100.00% | 0.41% |
STATE STREET CORP | 08/14/2024 | 124,749 | $159,679 | -73.17% | 0.40% |
MILLENNIUM MANAGEMENT LLC | 08/14/2024 | 122,752 | $157,123 | 172.03% | 0.40% |
MORGAN STANLEY | 10/17/2024 | 116,563 | $149,200 | -47.56% | 0.38% |
GOLDMAN SACHS GROUP INC | 08/13/2024 | 98,967 | $126,677 | 334.64% | 0.32% |
PENNANT INVESTORS, LP | 08/14/2024 | 83,900 | $107,392 | 0.00% | 0.27% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 80,400 | $102,912 | 9.99% | 0.26% |
Y-INTERCEPT (HONG KONG) LTD | 08/14/2024 | 74,922 | $95,900 | 100.00% | 0.24% |
BANK OF AMERICA CORP /DE/ | 08/14/2024 | 73,426 | $93,985 | 55.01% | 0.24% |
CITADEL ADVISORS LLC | 08/14/2024 | 65,800 | $84,224 | -15.32% | 0.21% |
VIRTU FINANCIAL LLC | 08/09/2024 | 57,338 | $73,000 | 309.85% | 0.19% |
CITIGROUP INC | 08/12/2024 | 55,775 | $71,392 | 1,486.77% | 0.18% |
HRT FINANCIAL LP | 08/12/2024 | 53,010 | $67,000 | 100.00% | 0.17% |
UBS GROUP AG | 08/14/2024 | 52,483 | $67,177 | -64.34% | 0.17% |
FEDERATED HERMES, INC. | 08/08/2024 | 50,251 | $64,321 | 4.89% | 0.16% |
XTX TOPCO LTD | 08/12/2024 | 46,503 | $59,524 | 48.99% | 0.15% |
TOCQUEVILLE ASSET MANAGEMENT L.P. | 08/12/2024 | 43,750 | $56,000 | -9.33% | 0.14% |
ARETE WEALTH ADVISORS, LLC | 08/14/2024 | 43,500 | $56,000 | 100.00% | 0.14% |
HENNION & WALSH ASSET MANAGEMENT, INC. | 07/19/2024 | 40,599 | $51,967 | 8.55% | 0.13% |
THRIVENT FINANCIAL FOR LUTHERANS | 08/13/2024 | 40,000 | $51,000 | 0.00% | 0.13% |
DIVERSIFY WEALTH MANAGEMENT, LLC | 08/08/2024 | 40,000 | $36,804 | 100.00% | 0.13% |
ROSALIND ADVISORS, INC. | 07/12/2024 | 39,672 | $50,780 | 100.00% | 0.13% |
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 07/26/2024 | 38,050 | $49,000 | 0.00% | 0.12% |
CENTIVA CAPITAL, LP | 08/14/2024 | 37,400 | $47,872 | 100.00% | 0.12% |
SQUAREPOINT OPS LLC | 08/14/2024 | 34,257 | $43,849 | 100.00% | 0.11% |
SIMPLEX TRADING, LLC | 07/25/2024 | 32,292 | $41,000 | 125.49% | 0.10% |
BANK OF MONTREAL /CAN/ | 08/14/2024 | 31,308 | $41,953 | -25.65% | 0.10% |
POINT72 ASIA (SINGAPORE) PTE. LTD. | 09/16/2024 | 30,295 | $38,778 | 100.00% | 0.10% |
COMMONWEALTH EQUITY SERVICES, LLC | 07/31/2024 | 25,400 | $33,000 | 100.00% | 0.08% |
VERITION FUND MANAGEMENT LLC | 08/14/2024 | 25,155 | $32,198 | 100.00% | 0.08% |
PALOMA PARTNERS MANAGEMENT CO | 08/14/2024 | 23,050 | $29,504 | 100.00% | 0.07% |
DAVENPORT & CO LLC | 08/06/2024 | 21,205 | $27,142 | -38.33% | 0.07% |
CITADEL ADVISORS LLC | 08/14/2024 | 20,500 | $26,240 | 72.27% | 0.07% |
US BANCORP \DE\ | 08/07/2024 | 18,468 | $23,639 | 2.41% | 0.06% |
LPL FINANCIAL LLC | 08/07/2024 | 18,402 | $23,555 | 100.00% | 0.06% |
RAYMOND JAMES & ASSOCIATES | 07/19/2024 | 17,731 | $22,696 | -4.32% | 0.06% |
CAPITAL INVESTMENT ADVISORY SERVICES, LLC | 08/14/2024 | 17,725 | $22,688 | -0.56% | 0.06% |
SEACREST WEALTH MANAGEMENT, LLC | 07/22/2024 | 15,750 | $20,160 | -8.70% | 0.05% |
POINT72 (DIFC) LTD | 09/16/2024 | 15,403 | $19,716 | 100.00% | 0.05% |
BioXcel Therapeutics, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of BTAI shares?
During the previous two years, 75 institutional investors and hedge funds held shares of BioXcel Therapeutics, Inc.. The most heavily invested institutionals were:
BlackRock Funding, Inc. /DE: 362,486
GEODE CAPITAL MANAGEMENT, LLC: 298,043
WELLS FARGO & COMPANY/MN: 185,058
RENAISSANCE TECHNOLOGIES LLC: 129,869
MILLENNIUM MANAGEMENT LLC: 128,773
BANK OF AMERICA CORP /DE/: 83,701
-
What percentage of BioXcel Therapeutics, Inc. stock is owned by institutional investors?
31.66% of BioXcel Therapeutics, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at BTAI ?
Institutional investors have bought a total of 2.20 M shares in the last 24 months. This purchase volume represents approximately $1.10 M in transactions.